Active	Status	Sponsor type	Region	Phase	Filter
5 Active 0 Inactive 5 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

5 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Arvat, Emanuela
LIBRETTO-531, NCT04211337 / 2019-001978-28: A Study of Selpercatinib (LY3527723) in Participants With RET-Mutant Medullary Thyroid Cancer	Active, not recruiting	3	291	Europe, Canada, Japan, US, RoW	Selpercatinib, LY3527723, LOXO-292, Cabozantinib, Vandetanib	Loxo Oncology, Inc., Eli Lilly and Company	Medullary Thyroid Cancer	05/23	02/26
NCT06645951: Institution of an Italian Multicenter Database of Patients With Parathyroid Carcinoma or Atypical Parathyroid Adenoma	Not yet recruiting	N/A	300	Europe		F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore	Parathyroid Gland Carcinoma, Parathyroid Gland Atypical Adenoma	11/34	11/34
NCT06645899: Institution of an Italian Multicenter Database of Patients Affected by Hypoparathyroidism or Pseudohypoparathyroidism	Not yet recruiting	N/A	600	Europe		F.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore	Hypoparathyroidism, Pseudo Hypoparathyroidism	11/34	11/34
ITCO, NCT04031339: Study of Clinical Outcomes of Thyroid Cancer	Recruiting	N/A	15000	Europe	Standard treatment	University of Roma La Sapienza, Italian Thyroid Cancer Observatory (ITCO) Foundation, Catholic University of the Sacred Heart	Thyroid Neoplasms	01/25	01/25
NCT04282083: Protocol ITANET - Registry	Recruiting	N/A	3600	Europe		Italian Association Neuroendocrine Tumors	Gastro-entero Pancreatic Neuroendocrine Tumors	07/27	07/32